3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Active not recruiting 1, Recruiting 1 |
Follow seladelpar: new trials by email Literature Review of seladelpar trials Research Report on seladelpar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Seladelpar, Placebo - Primary Biliary Cholangitis | Phase 3 | Recruiting | Gilead Sciences | 402 | 2023-09-07 | 2026-10-06 |
| Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) Seladelpar 10 mg, Placebo - Primary Biliary Cholangitis | Phase 3 | Completed | Gilead Sciences | 96 | 2023-09-05 | 2026-06-04 |
| RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) Seladelpar 10 mg, Placebo, Seladelpar 5 mg - Primary Biliary Cholangitis | Phase 3 | Completed | Gilead Sciences | 193 | 2021-04-21 | 2024-09-05 |
| ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) seladelpar 5-10 mg, seladelpar 10 mg, Placebo - Primary Biliary Cholangitis | Phase 3 | Completed | Gilead Sciences | 265 | 2018-10-01 | 2022-08-02 |
| Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) Seladelpar 5 mg Capsule, Seladelpar 10 mg Capsule - Primary Biliary Cirrhosis | Phase 3 | Active not recruiting | Gilead Sciences | 340 | 2017-12-12 | 2026-05-04 |
Gilead Sciences (5)
Canada (5) · United States (5) · Argentina (4) · Australia (4) · Austria (4) · Belgium (4) · Chile (4) · France (4) · Germany (4) · Greece (4) · Hungary (4) · Israel (4) · Italy (4) · Mexico (4) · Poland (4)
PMID 37904314, PMID 38381664, PMID 40553148, PMID 41933275, PMID 42798953